Approximately 12% of all human cancers are caused by oncoviruses. Human viral
oncogenesis is complex, and only a small percentage of the infected individuals develop …

Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …

Background It is generally stated that oral antiviral therapy in patients with chronic hepatitis
B (CHB) decreases the risk of developing hepatocellular carcinoma (HCC). Although oral …

Chronic hepatitis B virus (HBV) infection remains the number one risk factor for
hepatocellular carcinoma (HCC), accounting for more than 600 000 deaths/year. Despite …

Chronic hepatitis B virus (HBV) infection has been identified as a major risk factor in
hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. The …

Chronic infection with hepatitis B virus (HBV) is a risk factor for developing liver diseases
such as hepatocellular carcinoma (HCC). HBx is a multifunctional protein encoded by the …

Chronic active hepatitis (CAH) is acknowledged as an imperative risk factor for the
development of liver injury and hepatocellular carcinoma. The histological end points of …

Hepatitis B virus (HBV) is a human pathogen that has infected an estimated two billion
people worldwide. Despite the availability of highly efficacious vaccines, universal screening …

The hepatitis B virus (HBV) X protein (HBx) is thought to play a key role in HBV replication
and the development of liver cancer. It became apparent that HBx induces mitochondrial …

Hepatitis B virus X (HBx) protein is an important regulator of hepatic steatosis observed in
patients with hepatitis B virus; however, its underlying molecular mechanism remains …